GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » 3-Year ROIIC %

Aroa Biosurgery (ASX:ARX) 3-Year ROIIC % : -3.61% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Aroa Biosurgery's 3-Year ROIIC % for the quarter that ended in Mar. 2024 was -3.61%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Aroa Biosurgery's 3-Year ROIIC % or its related term are showing as below:

ASX:ARX's 3-Year ROIIC % is ranked worse than
50.96% of 830 companies
in the Medical Devices & Instruments industry
Industry Median: -3.005 vs ASX:ARX: -3.61

Aroa Biosurgery 3-Year ROIIC % Historical Data

The historical data trend for Aroa Biosurgery's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery 3-Year ROIIC % Chart

Aroa Biosurgery Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
3-Year ROIIC %
- - - - -3.61

Aroa Biosurgery Semi-Annual Data
Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
3-Year ROIIC % Get a 7-Day Free Trial - - - - -3.61

Competitive Comparison of Aroa Biosurgery's 3-Year ROIIC %

For the Medical Devices subindustry, Aroa Biosurgery's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aroa Biosurgery's 3-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aroa Biosurgery's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Aroa Biosurgery's 3-Year ROIIC % falls into.



Aroa Biosurgery 3-Year ROIIC % Calculation

Aroa Biosurgery's 3-Year ROIIC % for the quarter that ended in Mar. 2024 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -15.6416624 (Mar. 2024) - -14.5299144 (Mar. 2021) )/( 70.719 (Mar. 2024) - 39.891 (Mar. 2021) )
=-1.111748/30.828
=-3.61%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Aroa Biosurgery  (ASX:ARX) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Aroa Biosurgery 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aroa Biosurgery (ASX:ARX) Business Description

Traded in Other Exchanges
N/A
Address
64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022
Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines